CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,242,786
- in 10 filings, $10.6M under 10b5-1 plans
Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-03 | Weiss Amir Chief Accounting Officer | Option exercise | +5,179 | 19,074 | ||
| 2024-03-03 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −5,179 | 15,538 | ||
| 2024-02-28 | Bergwerk Dov Acting Chief Legal Officer | Option exercise | +6,653 | 96,983 | ||
| 2024-02-28 | Bergwerk Dov Acting Chief Legal Officer | Option exercise · Restricted Share Units | −6,653 | 0 | ||
| 2024-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +18,430 | 124,222 | ||
| 2024-02-28 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −18,430 | 0 | ||
| 2024-02-28 | Sabag Mark EVP, International Markets | Option exercise | +20,599 | 342,281 | ||
| 2024-02-28 | Sabag Mark EVP, International Markets | Option exercise · Restricted Share Units | −20,599 | 0 | ||
| 2024-02-28 | Weiss Amir Chief Accounting Officer | Option exercise | +3,219 | 13,895 | ||
| 2024-02-28 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −3,219 | 0 | ||
| 2024-02-28 | Drape Eric Executive VP Global Operations | Option exercise 10b5-1 | +19,515 | 19,516 | ||
| 2024-02-28 | Drape Eric Executive VP Global Operations | Sale 10b5-1 | −9,815 | $13.12 | $129K | 9,701 |
| 2024-02-28 | Drape Eric Executive VP Global Operations | Option exercise · Restricted Share Units 10b5-1 | −19,515 | 0 | ||
| 2024-02-28 | Daniell Richard Exec. VP, European Commercial | Option exercise 10b5-1 | +20,599 | 90,369 | ||
| 2024-02-28 | Daniell Richard Exec. VP, European Commercial | Sale 10b5-1 | −20,599 | $13.12 | $270K | 69,770 |
| 2024-02-28 | Daniell Richard Exec. VP, European Commercial | Option exercise · Restricted Share Units 10b5-1 | −20,599 | 0 | ||
| 2024-02-28 | Conway Vikki L See "Remarks" | Option exercise 10b5-1 | +4,294 | 4,294 | ||
| 2024-02-28 | Conway Vikki L See "Remarks" | Sale 10b5-1 | −1,366 | $13.12 | $18K | 2,928 |
| 2024-02-28 | Conway Vikki L See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −4,294 | 0 | ||
| 2024-02-16 | Drape Eric Executive VP Global Operations | Sale | −173,261 | $13.05 | $2.3M | 1 |
Page 25 of 76 · 1,517 trades